News

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
This includes terminating awards and contracts with pharmaceutical companies and universities and canceling 22 investment ...
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
There have been no changes to the licensing and royalty agreements related to mRNA research that have netted the university ...
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...